Congrats to all Moderna shareholders.. it's like striking lottery. On the flip side, a continuously weakened USD is really not much help to my entire portfolio. Whether to stay invested in USD or to stay clear is a growing conundrum for me.
Moderna had its best day ever Wednesday: shares soared 177% after its melanoma vaccine, developed with Merck, became the first mRNA cancer therapy to succeed in a Phase 3 trial. Merck rose alongside i...


